However, our results do not necessarily suggest that everyone with type 2 diabetes should receive an SGLT2i, nor do they address other considerations about widespread SGLT2i use
Song W, Zhang M, Teng L, Wang Y, Zhu L
Knowing your genetic predisposition before considering combination therapy allows your provider to distinguish between truly inadequate response to semaglutide monotherapy versus suboptimal dose, lifestyle factors, or adherence issues
The total number of experiments included in this study was small compare to other systematic reviews
A Comprehensive Weight Loss Solution Beyond Medication: A Holistic Strategy Support and Guidance: Martin's Wellness provides ongoing support, ensuring that you're not only receiving the medication but also the encouragement and advice needed to succeed